These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 19170193

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F, Russo G, Di Mitri R, Marino A.
    Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
    Rosales-Zábal JM, Fernández-Pérez F, Albandea-Moreno C, Vera-Rivero FM, Navarro-Jarabo JM.
    Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P, Van Assche G, Vermeire S.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):451-63. PubMed ID: 16441465
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
    Puli SR, Benage DD.
    Am J Gastroenterol; 2003 Apr 15; 98(4):939-40. PubMed ID: 12738486
    [No Abstract] [Full Text] [Related]

  • 30. Improving access for anti-tumour necrosis factor-a therapy in inflammatory bowel disease.
    Biehl NA, Pawlik J, Forbes GM.
    Med J Aust; 2010 Nov 01; 193(9):556-7. PubMed ID: 21034395
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
    Joosten AA, van Olffen GH, Hageman G.
    Ned Tijdschr Geneeskd; 2003 Jul 26; 147(30):1470-2. PubMed ID: 12908351
    [Abstract] [Full Text] [Related]

  • 34. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S, Kamm MA.
    Lancet; 2000 Mar 11; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalù AB.
    Recenti Prog Med; 2006 Feb 11; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [Abstract] [Full Text] [Related]

  • 37. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy.
    Rampton DS.
    Gut; 2005 Oct 11; 54(10):1360-2. PubMed ID: 16113045
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.
    Park SH, Kim YH, Lee JH, Kwon HJ, Lee SH, Park DI, Kim HK, Cheon JH, Im JP, Kim YS, Lee SY, Lee SJ.
    Expert Rev Gastroenterol Hepatol; 2015 Oct 11; 9 Suppl 1():35-44. PubMed ID: 26395533
    [Abstract] [Full Text] [Related]

  • 40. Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.
    Seiderer J, Göke B, Ochsenkühn T.
    Digestion; 2004 Oct 11; 70(1):3-9. PubMed ID: 15297773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.